Effect of epigallocatechin-3-gallate on iron overload in mice with alcoholic liver disease

Molecular Biology Reports

Volumn 38, Issue 2, 2011, Pages 879-886

  Ren, Yuan ^a   Deng, Fengjun ^a   Zhu, Hang ^a   Wan, Weiren ^a   Ye, Jufeng ^a   Luo, Bingde ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

ALD; EGCG; Hepcidin; Iron overload; Tf; TfR1

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; ASPARTATE AMINOTRANSFERASE; CD71 ANTIGEN; EPIGALLOCATECHIN GALLATE; HEPCIDIN; IRON; MALONALDEHYDE; MESSENGER RNA; TRANSFERRIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL LIVER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MECHANISM; HISTOPATHOLOGY; IRON BLOOD LEVEL; IRON METABOLISM; IRON OVERLOAD; LIVER INJURY; LIVER PROTECTION; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; CATECHIN; IRON; IRON OVERLOAD; LIVER; LIVER DISEASES, ALCOHOLIC; MALE; MALONDIALDEHYDE; MICE; MICE, INBRED C57BL; MODELS, BIOLOGICAL; RECEPTORS, TRANSFERRIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFERRIN;

MUS;

EID: 79951577451     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-010-0180-5     Document Type: Article

References (47)

1. E Albano 2006 Alcohol, oxidative stress and free radical damage Proc Nutr Soc 65 278 290 1:CAS:528:DC%2BD28XhtFWlu7zL 10.1079/PNS2006496 16923312 (Pubitemid 46323842)
2. A Dey AI Cederbaum 2006 Alcohol and oxidative liver injury Hepatology 43 S63 S74 1:CAS:528:DC%2BD28XhvVSkt7k%3D 10.1002/hep.20957 16447273
3. RW Chapman MY Morgan M Laulicht AV Hoffbrand S Sherlock 1982 Hepatic iron stores and markers of iron overload in alcoholics and patients with idiopathic hemochromatosis Dig Dis Sci 27 909 916 1:STN:280:DyaL3s%2Fgtlahtw%3D%3D 10.1007/BF01316575 7117074 (Pubitemid 12018917)
4. BJ Potter RW Chapman RM Nunes D Sorrentino S Sherlock 1985 Transferrin metabolism in alcoholic liver disease Hepatology 5 714 721 1:STN:280: DyaL2M3oslSmsw%3D%3D 10.1002/hep.1840050503 4029886 (Pubitemid 15236612)
5. MG Irving JW Halliday LW Powell 1988 Association between alcoholism and increased hepatic iron stores Alcohol Clin Exp Res 12 7 13 1:CAS:528: DyaL1cXht1GqtLg%3D 10.1111/j.1530-0277.1988.tb00124.x 3279862 (Pubitemid 18069082)
6. TM De Feo S Fargion L Duca BM Cesana L Boncinelli P Lozza MD Cappellini G Fiorelli 2001 Non-transferrin-bound iron in alcohol abusers Alcohol Clin Exp Res 25 1494 1499 10.1111/j.1530-0277.2001.tb02152.x 11696670 (Pubitemid 32976835)
7. JB Whitfield G Zhu AC Heath LW Powell And NG Martin 2001 Effects of alcohol consumption on indices of iron stores and of iron stores on alcohol intake markers Alcohol Clin Exp Res 25 1037 1045 1:CAS:528:DC%2BD3MXlvFaju78%3D 10.1111/j.1530-0277.2001.tb02314.x 11505030 (Pubitemid 32656121)
8. GN Ioannou JA Dominitz NS Weiss PJ Heagerty KV Kowdley 2004 The effect of alcohol consumption on the prevalence of iron overload, iron deficiency, and iron deficiency anemia Gastroenterology 126 1293 1301 1:CAS:528: DC%2BD2cXksF2qtLo%3D 10.1053/j.gastro.2004.01.020 15131790 (Pubitemid 38552794)
9. Halliwell B (1978) Superoxide-dependent formation of hydroxyl radicals in the presence of iron chelates. Is it a mechanism for hydroxyl radical production in biochemical systems? FEBS Lett 92:321-326 (Pubitemid 9002508)
10. H Tsukamoto W Horne S Kamimura O Niemela S Parkkila S Yla-Herttuala GM Brittenham 1995 Experimental liver cirrhosis induced by alcohol and iron J Clin Invest 96 620 630 1:CAS:528:DyaK2MXmslyqtrc%3D 10.1172/JCI118077 7615836
11. LG Valerio Jr T Parks DR Petersen 1996 Alcohol mediates increase in hepatic and serum nonheme iron stores in a rat model for alcohol-induced liver injury Alcohol Clin Exp Res 20 1352 1361 1:CAS:528:DyaK2sXivVCjsg%3D%3D 10.1111/j.1530-0277.1996.tb01134.x 8947310 (Pubitemid 26393935)
12. Y Suzuki H Saito M Suzuki Y Hosoki S Sakurai Y Fujimoto Y Kohgo 2002 Up-regulation of transferrin receptor expression in hepatocytes by habitual alcohol drinking is implicated in hepatic iron overload in alcoholic liver disease Alcohol Clin Exp Res 26 26S 31S 1:CAS:528:DC%2BD38XntFels7w%3D 12198371 (Pubitemid 34913182)
13. T Gantz 2004 Hepcidin in iron metabolism Curr Opin Hematol 11 251 254 10.1097/00062752-200407000-00004 (Pubitemid 39120953)
14. M Knutson M Wessling-Resnick 2003 Iron metabolism in the reticuloendothelial system Crit Rev Biochem Mol Biol 38 61 88 1:CAS:528:DC%2BD3sXisFakt7Y%3D 10.1080/713609210 12641343 (Pubitemid 36308351)
15. G Nicolas M Bennoun I Devaux C Beaumont B Grandchamp A Kahn S Vaulont 2001 Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice Proc Natl Acad Sci USA 98 8780 8785 1:CAS:528:DC%2BD3MXls1Witbs%3D 10.1073/pnas.151179498 11447267 (Pubitemid 32678104)
16. G Nicolas L Viatte M Bennoun C Beaumont A Kahn S Vaulont 2002 Hepcidin, a new iron regulatory peptide Blood Cells Mol Dis 29 327 335 1:CAS:528: DC%2BD3sXlt1yksg%3D%3D 10.1006/bcmd.2002.0573 12547223
17. N Ganne-Carrie C Christidis C Chastang M Ziol F Chapel F Imbert-Bismut JC Trinchet C Guettier M Beaugrand 2000 Liver iron is predictive of death in alcoholic cirrhosis: a multivariate study of 229 consecutive patients with alcoholic and/or hepatitis C virus cirrhosis: a prospective follow up study Gut 46 277 282 1:CAS:528:DC%2BD3cXhtFyrtbg%3D 10.1136/gut.46.2.277 10644325 (Pubitemid 30305857)
18. RW Chapman MY Morgan R Bell S Sherlock 1983 Hepatic iron uptake in alcoholic liver disease Gastroenterology 84 143 147 1:CAS:528: DyaL3sXosVOgsQ%3D%3D 6847841 (Pubitemid 13198301)
19. JV Higdon B Frei 2003 Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions Crit Rev Food Sci Nutr 43 89 143 1:CAS:528:DC%2BD3sXjsl2ltrw%3D 10.1080/10408690390826464 12587987 (Pubitemid 38552312)
20. E Tedeschi H Suzuki M Menegazzi 2002 Antiinflammatory action of EGCG, the main component of green tea, through STAT-1 inhibition Ann N Y Acad Sci 973 435 437 1:CAS:528:DC%2BD38Xps1yitbw%3D 10.1111/j.1749-6632.2002.tb04678.x 12485906 (Pubitemid 36125048)
21. JD Lambert CS Yang 2003 Mechanisms of cancer prevention by tea constituents J Nutr 133 3262S 3267S 1:CAS:528:DC%2BD3sXotFKrtbw%3D 14519824 (Pubitemid 37222254)
22. Q Guo B Zhao M Li S Shen W Xin 1996 Studies on protective mechanisms of four components of green tea polyphenols against lipid peroxidation in synaptosomes Biochim Biophys Acta 1304 210 222 1:CAS:528:DyaK28XmvFaltLo%3D 8982267 (Pubitemid 26426992)
23. R Apak K Guclu M Ozyurek SE Karademir 2004 Novel total antioxidant capacity index for dietary polyphenols and vitamins C and E, using their cupric ion reducing capability in the presence of neocuproine: CUPRAC method J Agric Food Chem 52 7970 7981 1:CAS:528:DC%2BD2cXhtVWhsbjO 10.1021/jf048741x 15612784 (Pubitemid 40053683)
24. KA Stuart LM Fletcher AD Clouston SV Lynch DM Purdie P Kerlin DHG Crawford 2000 Increased hepatic iron and cirrhosis: no evidence for an adverse effect on patient outcome following liver transplantation Hepatology 32 1200 1207 1:CAS:528:DC%2BD3cXptVSjsr4%3D 10.1053/jhep.2000.20348 11093725
25. LW Powell 1975 The role of alcoholism in hepatic iron storage disease Ann N Y Acad Sci 252 124 134 1:STN:280:DyaE2M3gtlerug%3D%3D 10.1111/j.1749-6632. 1975.tb19149.x 1056721
26. SM Sadrzadeh AA Nanji PL Price 1994 The oral iron chelator, 1,2-dimethyl-3-hydroxypyrid-4-one reduces hepatic-free iron, lipid peroxidation and fat accumulation in chronically ethanol-fed rats J Pharmacol Exp therapy 269 632 636 1:CAS:528:DyaK2cXktVeju7o%3D (Pubitemid 24157331)
27. PE Starke JL Farber 1985 Ferric iron and superoxide ions are required for the killing of cultured hepatocytes by hydrogen peroxide. Evidence for the participation of hydroxy radicals formed by an iron-catalyzed Harber-Weiss reaction J Biol Chem 260 10099 10104 1:CAS:528:DyaL2MXltlKks78%3D 2991275 (Pubitemid 16244100)
28. I Sakaida ME Kyle JL Farber 1990 Autophagic degradation of protein generate s a pool of ferric iron required for the killing of cultured hepatocytes by an oxidative stress Mol Pharmacol 37 435 442 1:CAS:528: DyaK3cXitFClsbw%3D 2314391 (Pubitemid 20115603)
29. RJ Rothman A Serroni JL Farber 1992 Cellular pool of transient ferric iron, chelatable by deferoxamine and distinct from ferritin, that is involved in oxidative cell injury Mol Pharmacol 42 703 710 1:CAS:528:DyaK38XmsV2jsrk%3D 1435746 (Pubitemid 23027636)
30. I Sakaida K Kayano S Wasaki A Nagatomi Y Matsumura K Okita 1995 Protection against actaminophen-induced liver injury in vivo by an iron che lator, deferoxamine Scand J Gastroenterol 30 61 67 1:CAS:528:DyaK2MXjvVOhsbo%3D 10.3109/00365529509093237 7701253
31. P Stal I Johansson M Ingelamn-Sundberg K Hagen R Hultcrantz 1996 Hepatotoxicity induced by iron overload and alcohol. Studies on the role of chelatable iron, cytochrome P450 2E1 and lipid peroxidation J Hepatol 25 538 546 1:STN:280:DyaK2s%2FmvV2ltA%3D%3D 10.1016/S0168-8278(96)80214-5 8912154 (Pubitemid 26345899)
32. ME Kyle I Sakaida A Serroni JL Farber 1990 Metabolism of acetaminophen by cultured rat hepatocytes. Depletion of protein thiol groups without any loss of viability Biochem Pharmacol 40 1211 1218 1:CAS:528:DyaK3cXlvVCiurg%3D 10.1016/0006-2952(90)90385-X 2403376 (Pubitemid 20311930)
33. AS Tavill AM Qadri 2004 Alcohol and iron Semin Liver Dis 24 317 325 1:CAS:528:DC%2BD2cXosVKmurc%3D 10.1055/s-2004-832943 15349808 (Pubitemid 39167688)
34. A Shervington V Pawar S Menon D Thakkar R Rahima Patel 2009 The sensitization of glioma cells to cisplatin and tamoxifen by the use of catechin Mol Biol Rep 36 1181 1186 1:CAS:528:DC%2BD1MXjvFaqu74%3D 10.1007/s11033-008- 9295-3 18581255
35. Y Jiao JT Wilkinson E Christine Pietsch JL Buss W Wang R Planalp FM Torti SV Torti 2006 Iron chelation in the biological activity of curcumin Free Radic Biol Med 40 1152 1160 1:CAS:528:DC%2BD28Xis1egtbs%3D 10.1016/j.freeradbiomed. 2005.11.003 16545682
36. ST Kumamoto K Nagayama M Tabata 2001 Effects of pH and metal ions on antioxidative activities of catechins Biosci Biotechnol Biochem 65 126 132 1:CAS:528:DC%2BD3MXhtVGgt7g%3D 10.1271/bbb.65.126 11272815 (Pubitemid 33617450)
37. L Reznichenko T Amit H Zheng Y Avramovich-Tirosh MB Youdim O Weinreb S Mandel 2006 Reduction of iron-regulated amyloid precursor protein and beta-amyloid peptide by (-)-epigallocatechin-3-gallate in cell cultures: implications for iron chelation in Alzheimer's disease J Neurochem 97 527 536 1:CAS:528:DC%2BD28XksVyktLg%3D 10.1111/j.1471-4159.2006.03770.x 16539659
38. LN Grinberg H Newmark N Kitrossky E Rahamim M Chevion EA Rachmilewitz 1997 Protective effects of tea polyphenols against oxidative damage to red blood cells Biochem Pharmcol 9 973 978 10.1016/S0006-2952(97)00155-X (Pubitemid 27475235)
39. MG Goodin BJ Bray RJ Rosengren 2006 Sex- and strain-dependent effects of epigallocatechin gallate (EGCG) and epicatechin gallate (ECG) in the mouse Food Chem Toxicol 44 1496 1504 1:CAS:528:DC%2BD28Xmsl2isLc%3D 10.1016/j.fct.2006.04. 012 16762473 (Pubitemid 43994280)
40. PA Abboud PW Hake TJ Burroughs K Odoms M O'Connor P Mangeshkar HR Wong B Zingarelli 2008 Therapeutic effect of epigallocatechin-3-gallate in a mouse model of colitis Eur J Pharmacol 579 411 417 1:CAS:528:DC%2BD1cXivVOhtw%3D%3D 10.1016/j.ejphar.2007.10.053 18022615
41. M Sugata B Sarmistha M Sudeshna D Sukta KP Chinmay 2006 Epigallocatechin gallate induced apoptosis in Sarcoma180 cells in vivo: mediated by p53 pathway and inhibition in U1B, U4-U6 UsnRNAs expression Apoptosis 11 2267 2276 10.1007/s10495-006-0198-2 (Pubitemid 44885401)
42. Y Kohgo T Ohtake K Ikuta Y Suzuki Y Hosoki H Saito J Kato 2005 Iron accumulation in alcoholic liver diseases Alcohol Clin Exp Res 29 189S 193S 10.1097/01.alc.0000189274.00479.62 16344607 (Pubitemid 43194349)
43. T Ganz 2003 Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation Blood 102 783 788 1:CAS:528:DC%2BD3sXlvFCms7g%3D 10.1182/blood-2003-03-0672 12663437 (Pubitemid 36917762)
44. A Krause S Neitz HJ Magert A Schulz WG Forssmann P Schulze Knoppe K Adermann 2000 LEAP-1, a novel highly disulfided-bonded human peptide, exhibits antimicrobial activity FEBS Lett 480 147 150 1:CAS:528:DC%2BD3cXmt1Sju78%3D 10.1016/S0014-5793(00)01920-7 11034317
45. CH Park EV Valore AJ Waring T Ganz 2001 Hepcidin, a urinary antimicrobial peptide synthesized in the liver J Biol Chem 276 7806 7810 1:CAS:528: DC%2BD3MXitFKhtbo%3D 10.1074/jbc.M008922200 11113131
46. T Ohtake H Saito Y Hosoki M Inoue S Miyoshi Y Suzuki Y Fujimoto Y Kohgo 2007 Hepcidin is down-regulated in alcohol loading Alcohol Clin Exp Res 31 S2 S8 10.1111/j.1530-0277.2006.00279.x 17331161 (Pubitemid 46114908)
47. Y Kohgo T Ohtake K Ikuta Y Suzuki Y Torimoto J Kato 2008 Dysregulation of systemic iron metabolism in alcoholic liver diseases J Gastroenterol Hepatol 23 1 S78 S81 1:CAS:528:DC%2BD1cXkslKgtro%3D 10.1111/j.1440-1746.2007.05290.x 18336670 (Pubitemid 351389036)